New England Retina Consultants

Name

New England Retina Consultants

Legal name

New England Retina Consultants

Website

https://neretina.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Specialty Ophthalmology Services

NAICS

Offices of Physicians (62111)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Retina & Vitreous Specialists (HLAKAKAE)

akta.pro secondary industry

Ocular Imaging & Diagnostic Testing Centers (HLAKAKAN)

Keywords

• Vitreoretinal care
• Retinal disease treatment
• Ophthalmology practice
• Retinal surgery
• Clinical retina research

Headquarters

HQ city

Springfield

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

1. Medical Services Revenue: Revenue generated from providing medical and surgical retina care services including office visits, diagnostic tests (OCT, FA, ultrasonography), surgical procedures (vitrectomy, scleral buckle, pneumatic retinopexy), and intravitreal injections. The practice accepts insurance including Medicare, Medicaid, and major commercial carriers.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels1 record

Core offering

New England Retina Consultants is a physician-owned ophthalmology specialty practice that diagnoses and treats diseases of the retina, macula, and vitreous. The practice delivers comprehensive medical and surgical vitreoretinal care through advanced diagnostics (OCT, FA, ultrasonography), in-office treatment procedures (intravitreal injections, laser therapies, pneumatic retinopexy, cryotherapy, PDT), and outpatient retinal surgeries (vitrectomy, scleral buckle). It also operates the Retina Research Institute, conducting clinical trials for geographic atrophy, neovascular AMD, diabetic retinopathy, and other retinal conditions.

Product overview

New England Retina Consultants is a medical practice providing comprehensive vitreoretinal care through a unified service model combining diagnostic testing, medical treatments, and surgical procedures. The practice operates the Retina Research Institute for clinical trials alongside clinical services. Core offerings include diagnostic services (OCT, Fluorescein Angiography, Ultrasonography), treatment procedures (intravitreal injections, laser therapies, photodynamic therapy), and surgical procedures (vitrectomy, scleral buckle, pneumatic retinopexy). The practice serves patients with conditions including age-related macular degeneration, diabetic retinopathy, retinal detachment, macular hole/pucker, and other vitreoretinal diseases across Western Massachusetts, Southern Vermont, New York, and Connecticut.

Differentiator

Problem solved

Functional benefit

Brands

• Retina Research Institute: A facility completely dedicated to retinal investigations with active clinical trials for geographic atrophy, neovascular AMD, diabetic retinopathy, and other retinal conditions.

Products and services

• Vitrectomy Outpatient surgical procedure that removes the vitreous gel to treat conditions including retinal detachment, diabetic retinopathy, macular hole, macular pucker, and vitreous hemorrhage. Performed on patients with these specific vitreoretinal conditions.
• Scleral Buckle Surgical silicone band wrapped around the eye wall to support the retina and repair certain types of retinal detachments. Performed on patients with specific retinal detachment types.
• Pneumatic Retinopexy In-office procedure combining cryotherapy with gas bubble injection to repair certain types of retinal detachments. Performed on patients with qualifying retinal detachments.
• Retinal Laser Photocoagulation In-office laser procedure used to seal retinal tears and treat leaking blood vessels from diabetic retinopathy or retinal vein occlusion. Used for patients with these specific conditions.
• Laser Retinopexy Laser procedure to seal retinal tears and prevent retinal detachment development. Performed on patients with diagnosed retinal tears.
• Cryotherapy Freezing procedure applied to the sclera to treat retinal tears or leaking retinal blood vessels. Provided to patients with these specific retinal conditions.
• Intravitreal Injections Injection of medications including steroids, Avastin, Lucentis, or Eylea for treatment of wet macular degeneration, retinal vein occlusion, and diabetic retinopathy. Performed on patients with these qualifying conditions.
• Photodynamic Therapy (PDT) Office-based treatment using intravenous verteporfin and laser to treat central serous chorioretinopathy, wet macular degeneration, and certain eye tumors. Performed on patients with these diagnoses.
• Optical Coherence Tomography (OCT) Non-invasive imaging test that captures detailed cross-sectional images of the retina. Provided to patients for accurate diagnosis of retinal conditions.
• Fluorescein Angiography (FA) Diagnostic test using fluorescent dye to visualize blood flow through retinal vessels. Used for patients undergoing evaluation of retinal vascular conditions.
• Ultrasonography Non-invasive in-office procedure using sound waves to image the inside of the eye when view is obstructed by cataract or vitreous hemorrhage. Provided to patients with such obstructions.
• Retina Research Institute Clinical Trials Dedicated research facility conducting clinical trials for retinal conditions including geographic atrophy, neovascular AMD, diabetic retinopathy, and other retinal diseases. Offers patients access to investigational treatments through partnership with pharmaceutical companies.

Quantifiable outcome

• Vitrectomy for macular hole has 95-99% hole closure rate
• +3 more outcomes

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Six partnerships are on record, tiered core.

• Baystate Medical CentercoreStrategic or Co-development PartnerPhysicians serve as faculty members at Baystate Medical Center, providing attending surgical services and maintaining academic collaboration. Dr. Andrew Lam is an attending surgeon at Baystate Medical Center.
• Tufts University School of MedicinecoreStrategic or Co-development PartnerPhysicians hold faculty appointments at Tufts University School of Medicine. Dr. Lally completed fellowship at Tufts School of Medicine/Ophthalmic Consultants of Boston.
• UMass Chan Medical School-BaystatecoreStrategic or Co-development PartnerDr. David Lally serves as Clinical Assistant Professor at UMass Chan Medical School-Baystate, maintaining academic and clinical teaching relationships.
• Ophthalmic Consultants of BostoncoreStrategic or Co-development PartnerDr. Lally completed his vitreoretinal fellowship at Ophthalmic Consultants of Boston and the New England Eye Center at Tufts Medical Center. Dr. Gulati also completed fellowship training at Ophthalmic Consultants of Boston.
• Wills Eye HospitalcoreStrategic or Co-development PartnerMultiple physicians trained at Wills Eye Hospital including Dr. Andrew Lam (residency and fellowship), Dr. Rebecca Soares (residency and fellowship), and Dr. David Lally (residency). Wills Eye Hospital is a premier ophthalmology training institution.
• Multiple Pharmaceutical Companies (Clinical Trial Partners)coreStrategic or Co-development PartnerPractice serves as clinical trial site for pharmaceutical companies including Annexon Biosciences, Aviceda Therapeutics, Astellas, Regeneron Pharmaceuticals, Eyepoint Pharmaceuticals, Genentech, and others for trials in geographic atrophy, neovascular AMD, diabetic retinopathy, and other conditions.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Market position

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/new-england-retina-consultants-pc

Compliance7 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about New England Retina Consultants